| No. | Código | Descripción |
| 1 |
|
Speaking to Patients About Diabetes Risk: Is Terminology Important?
Valentina D. Tarasova, MD, Jaime A. Caballero, MD, Paul Turner, PhD, and Silvio E. Inzucchi, MD. (2014). Speaking to Patients About Diabetes Risk: Is Terminology Important?. Practical pointers. 2014. 91 Valentina D. Tarasova, MD, Jaime A. Caballero, MD, Paul Turner, PhD, and Silvio E. Inzucchi, MD |
2 |
|
Status of Diabetes Care: “It Just Doesn’t Get Any Better
William T. Cefalu,1 Andrew J.M. Boulton,2 William V. Tamborlane,3 Robert G. Moses,4 Derek LeRoith,5 . (2014). Status of Diabetes Care: “It Just Doesn’t Get Any Better. Diabetes Care. 2014. 4 William T. Cefalu,1 Andrew J.M. Boulton,2 William V. Tamborlane,3 Robert G. Moses,4 Derek LeRoith,5 |
3 |
|
The experience of thalassemic adults with their treatment
Marcela Ganzelia, Márcia Maria Fontâo Zago. (2011). The experience of thalassemic adults with their treatment. Latino-Am. Enfermagem. 2011. 10 Marcela Ganzelia, Márcia Maria Fontâo Zago |
4 |
|
Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Jane L. Chiang, M. Sue Kirkman, Lori M.B. Laffel, and Anne L. Peters. (2014). Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association. Diabetes Care. 2014. 21 Jane L. Chiang, M. Sue Kirkman, Lori M.B. Laffel, and Anne L. Peters |
5 |
|
Which Test for Diagnosing Early Human Diabetic Neuropathy?
Rayaz A. Malik. (2014). Which Test for Diagnosing Early Human Diabetic Neuropathy?. Diabetes. 2014. 3 Rayaz A. Malik |
6 |
|
AAA
ÑKÑLN. (2007). AAA. ÑÑ. LIHO. 0 ÑKÑLN |